Synthesis of 3-substituted bicyclic imidazo[1,2-d][1,2,4]thiadiazoles and tricyclic benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazoles

Journal of Organic Chemistry

Volumn 70, Issue 16, 2005, Pages 6230-6241

  Leung Toung, Regis ^a   Tam, Tim F ^a   Zhao, Yanqing ^a   Simpson, Craig D ^a   Li, Wanren ^a   Desilets, Denis ^a   Karimian, Khashayar ^a  

^a ApoPharma Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; AMINES; CRYSTAL STRUCTURE; ESTERS; NITRILE RESINS; ORGANIC COMPOUNDS; REACTION KINETICS; SCAFFOLDS; SUBSTITUTION REACTIONS;

METHYLATION; NITRILES; NUCLEOPHILES; PRECURSORS;

SYNTHESIS (CHEMICAL);

1,2,4 THIADIAZOLE DERIVATIVE; 2 BUTYLBENZO[4,5]IMIDAZP[1,2 D][1,2,4]THIADIAZOL 3(2H) ONE; 2 BUTYLIMIDAZO[1,2 D] 1,2,4 THIADIAZOLE 3(2H) ONE; 3 [(4 METHYLPHENYL)SULFONYL]IMIDAZO[1,2 D][1,2,4]THIADIAZOLE; 3 BROMOBENZO[4,5]IMIDAZO[1,2 D][1,2,4]THIADIAZOLE; 4 TOLUENESULFONYL CYANIDE; ALCOHOL; AMINE; CYANOGEN BROMIDE; MALONIC ACID; N [6 (IMIDAZO[1,2 D][1,2,4]THIADIAZOL 3 YLAMINO)HEXYL]NAPHTHALENE 1 SULFONAMIDE; N [6 [IMIDAZO[1,2 D][1,2,4]THIADIAZOL 3 YL (METHYL)AMINO]HEXYL] 2 NITROBENZENESULFONAMIDE; NITRILE; TOLUENE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CRYSTAL STRUCTURE; DEPROTECTION REACTION; DERIVATIZATION; METHYLATION; SYNTHESIS; X RAY ANALYSIS;

AMINES; BENZENE; CRYSTALLOGRAPHY, X-RAY; CYCLIZATION; CYSTEINE; IMIDAZOLES; MOLECULAR STRUCTURE; THIADIAZOLES;

EID: 23044459107     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0507486     Document Type: Article

References (51)

1. (a) Franz, J. E.; Dhingra, O. P. Compr. Heterocycl. Chem. I 1984, 6, 463-511.
2. (b) Wilkins, D. J.; Bradley, P. A. Compr. Heterocycl. Chem. II 1996, 4, 307-354.
3. (c) Kurzer, F. Adv. Heterocyd. Chem. 1982, 32, 285-398.
4. The CAS Registry No. for terrazole is 25-931-59.
5. (a) Unangst, P. C.; Shrum, G. P.; Connor, D. T.; Dyer, R. D.; Schrier, D. J. J. Med. Chem. 1992, 35, 3691-3698.
6. (b) Song, Y.; Connor, D. T.; Sercel, A. D.; Sorenson, R. J.; Doubleday: R.; Unangst, P. C.; Roth, B. D.; Beylin, V. G.; Gilbertsen, R. B.; Chan, K.; Schrier, D. J.; Guglietta, A.; Bornemeier, D. A.; Dyer, R. D. J. Med. Chem. 1999, 42, 1161-1169.
7. Smith, C. W.; Chakrabarti, J. K.; Williamson, W. R. N. Bioorg. Med. Chem. Lett. 1994, 4, 1673-1678.
8. Yousif, N. M. Egypt. J. Chem. 1989, 32, 597-605.
9. (a) van Muijlwijk-Koezen, J. E.; Timmerman, H.; Vollinga, R. C.; Frijtag von Drabbe Kunzel, J.; de Groote, M.; Visser, S.; Ijzerman, A. P. J. Med. Chem. 2001, 44, 749-762.
10. (b) van den Nieuwendijk, A. M.; Pietra, D.; Heitman, L.; Göblyös, A.; Ijzerman, A. P. J. Med. Chem. 2004, 47, 663-672.
11. (c) Göblyös, A.; de Vries, H.; Brussee, J.; Ijzerman, A. P. J. Med. Chem. 2005, 48, 1145-1151.
12. Antonio, Y.; Camargo, C.; Galeazzi, E.; Iriarte, J.; Guzman, M.; Muchowski, J. M.; Gerrity, K.; Liu, F.; Miller, L. M.; Strosberg, A. M. J. Med. Chem. 1978, 21, 123-126.
13. MacLeod, A. M.; Baker, R.; Freedman, S. B.; Patel, S.; Merchant, K. J.; Ros, M.; Saunders J. J. Med. Chem. 1990, 33, 2052-2059.
14. Collins, I.; Moyes, C.; Davey, W. B.; Rowley, M.; Bromidge, F. A.; Quirk, K.; Atack, J. R.; McKernan, R. M.; Thompson, S. A.; Wafford, K.; Dawson, G. R.; Pike, A.; Sohal, B.; Tsou, N. N.; Ball, R. G.; Castro, J. L. J. Med. Chem. 2002, 45, 1887-1900.
15. Cheng, X.-M. Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: London, 1996; Vol. 31, Chapter 34, pp 337-355; in particular p 339.
16. (a) For recent reviews on cysteine proteases, see the following: Leung-Toung, R.; Li, W.; Tam, T. F.; Karimian, K. Curr. Med. Chem. 2002, 9, 979-1002.
17. (b) Powers, J. C.; Asgian, J. L.; Ekici, Ö. D.; James, K. L. Chem. Rev. 2002, 12, 4639-4750.
18. (c) Donkor, I. O. Curr. Med. Chem. 2000, 7, 1171-1188.
19. (d) Talanian, R. V.; Brady, K. D.; Cryns, V. L. J. Med. Chem. 2000, 43, 3351-3371.
20. For a review on inhibitors targeting the cysteine residues of biomolecules, see the following: Scozzafava, A.; Casini, A.; Supuran, C. T. Curr. Med. Chem. 2002, 9, 1167-1185.
21. Bryson, S.; Pai, E. F.; Desilets, D.; Li W.; Tam T.; Karimian K. Evidence for the formation of a disulfide bond between cysteine proteases and 1,2,4-thiadiazoles; PENCE AGM 2000 Meeting, Montebello, Quebec, Canada, June 24-26, 2000; PENCE, Inc.: Edmonton, 2000.
22. (a) Crook, S.; Sykes, P. J. Chem. Soc., Perkin Trans. 1 1977, 1791-1796.
23. (b) Hagiwara, K.; Hashimoto, S.; Shimoda, S. J. Pestic. Sci. 1992, 17, 251-259.
24. (c) Newton, C. G.; Ollis, D. W. J. Chem. Soc., Perkin Trans. 1 1984, 75-84.
25. (a) Leung-Toung, R.; Wodzinska, J.; Li, W.; Lowrie, J.; Kukreja, R.; Desilets, D.; Karimian, K.; Tam, T. F. Bioorg. Med. Chem. 2003, 11, 5529-5537.
26. (b) Karimian, K.; Tam, T. F.; Leung-Toung, R. C. S. H.; Li, W.; Bryson, S.; Wodzinska, J. M. W00190095, 2001.
27. Marrano, C.; de Macedo, P.; Gagnon, P.; Lapierre, D.; Gravel, C.; Keillor, J. W. Bioorg. Med. Chem. 2001, 9, 3231-3241.
28. (a) Leung-Toung, R.; Tam, T. F.; Wodzinska, M. J.; Zhao, Y.; Lowrie, J.; Simpson, D. C.; Karimian, K.; Spino, M. J. Med. Chem. 2005, 48, 2266-2269.
29. (b) Tam, T. F.; Karimian, K.; Leung-Toung, R. C. S. H.; Zhao, Y.; Wodzinska, J. M.; Li, W.; Lowrie, J. N. US patent application 20030225007A1, 2003.
30. (a) Tam, F. T.; Leung-Toung, R.; Li, W.; Spino, M.; Karimian, K. Mini-Rev. Med. Chem. 2005, 5, 367-379.
31. (b) Tam, T.; Li, W.; Leung-Toung, R.; Karimian, K. IDrugs 2000, 3, 1064-1074.
32. (c) Karimian, K.; Tam, T. F.; Desilets, D.; Lee, S.; Cappelletto, T.; Li, W. US patent 5,677,302, 1997.
33. Haugwitz, R. D.; Toeplitz, B.; Gougoudas, J. Z. J. Chem. Soc., Chem. Commun. 1977, 736-737.
34. (a) Martin, D.; Tittelbach, F. Tetrahedron 1983, 35, 2311-2314.
35. (b) Martin, D.; Wenzel, A. J. Prakt. Chem. 1978, 320, 677-684.
36. (c) Martin, D.; Tittelbach, F. J. Chem. Soc., Perkin Trans. 1 1985, 1007-1013;
37. Pentimalli, L.; Milani, G.; Biavati, F. Gazz. Chim. Ital. 1977, 107, 1-5.
38. NAr substitution in heterocycles, see the following: (a) Chauvière, G. Bouteille, B.; Enanga, B.; de Albuquerque, C.; Croft, S. L.; Dumas, M.; Périé, J. J. Med. Chem. 2003, 46, 427-440.
39. (b) Song, Y.; Connor, D. T.; Sercel, A. D.; Sorenson, R. J.; Doubleday: R.; Unangst, P. C.; Roth, B. D.; Beylin, V. G.; Gilbertsen, R. B.; Chan, K.; Schrier, D. J.; Guglietta, A.; Bornemeier, D. A.; Dyer, R. D. J. Med. Chem. 1999, 42, 1161-1169.
40. (c) Zhang, Z.; Yin, Z.; Kadow, J. F.; Meanwell, N. A.; Wang, T. J. Org. Chem. 2004, 69, 1360-1363.
41. (d) Guillier, F.; Roussel, P.; Moser, H.; Kane, P.; Bradley, M. Chem. Eur. J. 1999, 5, 3450-3458.
42. (e) Liu, J.; Janeba, Z.; Robins, M. J. Org. Lett. 2004, 6, 2917-2919.
43. Other isocyanates (methyl, ethyl, propyl) work equally well. However, we settled for n-butyl isocyanate because of cost and safety (higher bp) considerations and commercial availability in kilogram quantity.
44. For a preparative procedure for p-TsCN, see the following, Vrijland, M. S. A. In Organic Syntheses; Noland, W. E., Ed; John Wiley & Sons, Inc.: Toronto, 1988; Collect. Vol. VI, pp 727-730.
45. We do not have a reasonable explanation for this observation. However, we also noted that 1,3-, 1,4-, and 1,6-alkyldiamines are available reasonably cheaply in kg's quantities from commercial suppliers, but 1,5-diaminopentane is supplied in small quantities (25 g bottle) and is relatively much more expensive.
46. +) and that of N2 was 10.72 (NH).
47. Braun, S.; Kalinowski, H.-O.; Berger, S. 150 and More Basic NMR Experiments: A Practical Course, 2nd expanded ed.; Wiley-VCH: Toronto, 1998.
48. Based on the experimental design (monitoring of 2-mercaptobenzimidazole), we cannot preclude the formation of an imine type intermediate like 28a or 28b in the case of 7f. However, in a different system and different conditions, the intermediates shown below were isolated (see ref 18c): (Diagram presented)
49. A major part of this work has been the subject of US patent 5,677,302, 1997 (ref 17b) and US patent application 20030225007A1, 2003 (ref 18c).
50. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.
51. 2 and its associated J value (≈ 6 Hz), see: Grehn, L.; Ragnarsson, U. J. Org. Chem. 2002, 67, 6557-6559.